Jaguar Health discusses FDA breakthrough therapy designation for rare disease treatment
Go back to Jaguar Health discusses FDA breakthrough therapy designation for rare disease treatment| (NASDAQ: JAGX) | Delayed: 2.25 -0.13 (5.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.38 | 52 Week High | $4.60 | |||
| Open | $2.38 | 52 Week Low | $0.81 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.12 | EPS | $0.00 | |||
| Volume | 216,456 | |||||
